Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.

@article{Walker2000PreventionOR,
  title={Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.},
  author={John Roger Walker and Michael Van Ameringen and Richard P. Swinson and Rudy Cecil Bowen and Pratap Rao Chokka and Elliot M. Goldner and Dean C.C. Johnston and Y J Lavallie and Sudip Nandy and John C. Pecknold and Vratislav Hadrava and Roger M. Lane},
  journal={Journal of clinical psychopharmacology},
  year={2000},
  volume={20 6},
  pages={
          636-44
        }
}
The aim of this study was to evaluate the efficacy, tolerability, and effects on quality of life of sertraline, a selective serotonin reuptake inhibitor, in the prevention of relapse of generalized social phobia. Fifty adult outpatients with generalized social phobia who were rated much or very much improved on the Clinical Global Impression Scale of Improvement (CGI-I) after 20 weeks of sertraline treatment (50-200 mg/day) were randomly assigned in a one-to-one ratio to either continue double… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Similar Papers

Loading similar papers…